Nutrition Excellence Unit 11A, 3325 North Service Road Burlington, Ontario L7N 3G2
Marketing Authorization Holder
N/A
Capsule
N/A
195mg per capsule
Reason
Yohimbine and its salts and derivatives are described in Schedule F, Part I of the Food and Drugs Regulations. The presence of the substance in an unapproved drug product represents an unacceptable risk to health.
Depth of distribution
The product is sold to independent retailers across Canada.